Abstract
Currently, implants are utilized clinically for bone transplant procedures. However, if infectious osteomyelitis occurs at implant sites, removal of bacteria can be challenging. Moreover, altered blood flow at peri-implant infectious sites can create an anaerobic environment, making it more difficult to treat infection with antibiotics. Thus, it would be beneficial if implants could be modified to exhibit antibacterial activity, even in anaerobic conditions. Here, we show antibacterial activity of silver ions coated on titanium rods, even against the anaerobic bacteria Porphyromonas gingivalis (P. gingivalis), both in vitro and in vivo. Specifically, we implanted silver-coated or control uncoated titanium rods along with P. gingivalis in mouse femoral bone BM cavities and observed significantly inhibited P. gingivalis infection with silver-coated compared with non-coated rods, based on in vivo bio-imaging. Osteonecrosis by infectious osteomyelitis and elevation of the inflammatory factors C-reactive protein and IL-6 promoted by P. gingivalis s were also significantly reduced in the presence of silver-coated rods. Overall, our study indicates that silver ion coating of an implant represents a therapeutic option to prevent associated infection, even in anaerobic conditions or against anaerobic bacteria.
Similar content being viewed by others
Introduction
To date, dental implants have been developed to replenish, restore or reinforce defective bone due to conditions like periodontitis, tumors or trauma. In orthopedic practice, other devices have been developed for joint replacement and fracture repair. Such implants are now in fact indispensable clinical tools to maintain or improve patients’ activities of daily living (ADL) and maintain their quality of life (QOL). However, once implant-associated infections occur, they can be difficult to cure, as implants have no inherent anti-bacterial activity. Also, some bacteria form antibiotic-resistant biofilms on implant surfaces, or the infectious region can become hypo-vascular due to granuloma formation1,2. In severe cases, implants must be removed to cleanse them of implant-associated infection, conditions that severely worsen patients’ ADL and QOL3,4,5. Risk of implant-associated infection is particularly high with dental implants, which are exposed to high levels of bacteria in the oral environment, including those that cause periodontitis6,7. Also, in orthopedics, infectious osteomyelitis is difficult to treat whether a patient has had an implant or not. Antibiotics and protocols for their use in these conditions have been developed to treat implant-associated infections8,9,10, but their effects vary in different contexts, such as loss of tissue-migrating capacity of agents owing to granulation or biofilm formation on the device surface11,12.
Development of implants with inherent antimicrobial activity is one approach to these issues but requires several considerations: implant strength cannot be reduced by acquisition of antimicrobial activity nor can the material that promotes antimicrobial activity exhibit cytotoxicity in vivo. Various means to satisfy these criteria have been developed13, including coating implants with silver ions, as they reportedly exhibit antimicrobial activity against Staphylococcus aureus and antagonize biofilm formation without cytotoxicity14,15. Silver ions reportedly provide antibacterial effects by promoting generation of reactive oxygen species in the presence of oxygen16,17, although underlying mechanisms remain unknown. Nonetheless, anaerobic bacteria often underlie implant infection, among them Porphyromonas gingivalis (P. gingivalis), which causes periodontitis and oral implant-associated infections, leading to implant failure18,19,20. Thus far it is not known whether silver ions exert antibacterial effects in anaerobic conditions or against anaerobic bacteria.
Here, we evaluated antimicrobial effects of silver ions against P. gingivalis in anaerobic conditions in vitro and found them effective, even in anaerobic conditions. Given that titanium is frequently used for implant material, we then coated titanium rods with silver ions and found that they exhibited antimicrobial activity greater than that of uncoated controls against PGs in anaerobic conditions in vitro and in in vivo. Specifically, P. gingivalis levels in mouse femoral bones, as detected using a fluorescence-based probe, decreased more rapidly in the presence of titanium rods coated with silver ions than with uncoated control rods. Histologically, osteonecrosis development owing to P. gingivalis -dependent infectious osteomyelitis was significantly inhibited when titanium rods were coated with silver ions. Similarly, serum levels of inflammatory C-reactive protein (CRP) and IL-6 increased following P. gingivalis transplantation in mouse femur, an increase significantly blocked when silver ion-coated titanium rods were present. Taken together, these results indicate that ionic silver coating is a clinically useful option to prevent implant-associated infections in anaerobic conditions or following infection with anaerobic bacteria.
Results
Silver ions exhibit antimicrobial activity against the anaerobic bacteria Porphyromonas gingivalis in vitro
To test if silver ions (Ag+) have antimicrobial activity against anaerobic bacteria, we treated Porphyromonas gingivalis (P. gingivalis)-inoculated agar gels with various concentrations of silver nitrate (AgNO3; 169.87) solution in anaerobic conditions (5% CO2, 10% H2, balanced N2). After 48 h of cultivation, we assessed antimicrobial activity on plates based on formation of inhibition circles and detected dose-dependent antimicrobial activity of silver nitrate against P. gingivalis’s (Fig. 1). AgNO3 antimicrobial activity reached a plateau at 1.56 × 10–4 M.
Titanium implants are frequently used for oral and orthopedic surgery as they are rustproof and safe for patients undergoing magnetic resonance imaging (MRI)21,22,23. To evaluate antimicrobial activity of Ag+ against P. gingivalis’s in vitro, we first coated titanium rods (Ti) with Ag+. To do so, we precoated rods with hydroxyapatite (HAp) to form a HAp film surface on the implant, which was then modified by treatment with IP6 (C6H6 (OPO3H2)6). Ag+ ions were then immobilized on the modified film by IP6 chelation to yield HAp-IP6-Ag+–Ti. We then placed HAp-IP6-Ag+–Ti or one of three different control rods—non-coated (Ti), coated with HAp alone, or coated with HAp and IP6—on gels inoculated with PG and compared antimicrobial activity against P. gingivalis growing in anaerobic conditions. Only the HAp-IP6-Ag+–Ti rod exerted anti-P. gingivalis activity, based on formation of an inhibition circle on the agar gel around that rod (Fig. 2a,b). Antimicrobial activities of HAp-IP6-Ag+–Ti rods were tested at day seven, month eight and four years after application of the silver ion coating (Fig. 2a–c), and that activity was equivalent among rods. Thus, antimicrobial activities of HAp-IP6-Ag+–Ti rods were maintained for at least four years. However, HAp-IP6-Ag+–Ti rods did not promote cytotoxicity in in vitro cell culture, and the number of living cells cultured with HAp-IP6-Ag+–Ti (Ag + (5)) or control (HAp-IP6) rods was equivalent. (Fig. 2d). These analyses indicate that Ag+ ions exert anti-P. gingivalis activity in anaerobic conditions, even when coated onto titanium rods, without promoting cytotoxicity.
Silver ion-coating of titanium rods prevents Porphyromonas gingivalis infection in vivo
To determine whether Ag+ coating of titanium rods antagonizes implant-associated P. gingivalis infection, we established a P. gingivalis-based infectious osteomyelitis model based in mice (Fig. 3a,b). To do so, we transplanted P. gingivalis’s into femoral bone marrow cavities in eight-week-old female wild-type mice. We also implanted Ag+ coated HAp-IP6-Ag+–Ti or control HAp-IP6-Ti rods in those same bone marrow cavities and, at the same time, injected mice intraperitoneally with IVISense Bacterial 750 Fluorescent Probe. One day later, we began performing in vivo imaging of fluorescent signals over 7 days using in vivo imaging (Fig. 3c). No fluorescence activity was detected in sterile controls (Ti rods without P. gingivalis transplantation) at day one after surgery (Figure S1). In mice implanted with HAp-IP6-Ag+–Ti rods, fluorescent signals indicative of bacteria decreased faster than in control mice, and by day 7 fluorescence was not detectable in mice implanted with HAp-IP6-Ag+–Ti rods. By contrast, on day 7 HAp-IP6-Ti mice still showed detectable fluorescence (Fig. 3c).
We confirmed these findings in immunohistochemical analysis and, using an anti-P. gingivalis antibody, were able to detect P. gingivalis in bone marrow cavities, indicating that infectious osteomyelitis by P. gingivalis was established in bone marrow cavities implantated with HAp-IP6-Ti at day 14 (Fig. 4). However, such P. gingivalis infection in bone marrow cavities was clearly eliminated by HAp-IP6-Ag+–Ti rod implantation (Fig. 4).
We then used histology and biomarker analysis to evaluate effects of Ag+ coating of rod implants in mice (Figs. 5, 6). To do so, we established infectious osteomyelitis models of P. gingivalis’s with HAp-IP6-Ag+–Ti or HAp-IP6-Ti rods as above, collected peripheral blood samples on days 1, 3, 5, 7 and 14, and then euthanized animals for histological analysis of the femur on day 14. Sterile controls were included as the Sham group. Examination of femoral bone revealed that the extent of infectious osteonecrosis, based on formation of empty lacunae, was significantly less in HAp-IP6-Ag+–Ti compared to control mice (Fig. 5a–c). Relevant to biomarkers, levels of C-reactive protein (CRP), an early inflammatory marker used clinically to monitor infection and inflammation, were significantly lower in blood of HAp-IP6-Ag+–Ti mice at early stages after surgery (Fig. 6a). Likewise, serum levels of the inflammatory cytokine IL-6 were significantly lower in HAp-IP6-Ag+–Ti relative to control mice by seven days after surgery (Fig. 6b).
Discussion
To maintain patients’ ADL and QOL, methods to prevent implant-associated infection after bone implant are crucial, as these infections are difficult to treat and if severe can require removal of the implanted device to eradicate infection24. Various methods are used to block or minimize implant-associated infection, such as air purification via use of HEPA filters or antibiotic treatment at the time of surgery10,25,26. Nonetheless, these approaches are partially successful, and implant-associated infections still occur27. Here, we demonstrate that coating a titanium implant with silver ions can prevent implant-associated infections, even those induced by anaerobic bacteria.
To date, strategies to modify implant surfaces have been considered to prevent implant-associated infection, such as treatment with antibiotics, iodine or silver coating28,29,30,31. Coating with antibiotics is effective only against some bacteria, and minimally effective against multi-drug resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA). Although the full spectrum of silver’s antibacterial activity has not yet been defined, silver ions are reportedly effective against the aerobic bacteria Staphylococcus aureus (S. Aureus)14. Here, we show that silver coating is also effective against anaerobic bacteria infection in vitro and in vivo, even in the bone marrow cavity. This latter finding is particularly significant, as oxygen has been thought critical for antibacterial activities of silver32.
P. gingivalis infection is typically seen in oral or maxillofacial bones; however, creating infectious osteomyelitis models in mouse via implantation in those bones is technically difficult due to animal size. Instead, we were successful in establishing infectious osteomyelitis in mice by P. gingivalis infection with implanting titanium rods in femoral bone marrow cavities. That analysis supported the idea that silver coating of implants provides antimicrobial activities against P. gingivalis in those cavities.
P. gingivalis is known to form biofilms on implants33. Thus, the antimicrobial activity of an ionic silver coating is likely due to inhibition of biofilm formation. Indeed, coating of implants with ionic silver has been shown to inhibit biofilm formation by S. Aureus34. However, P. gingivalis is reportedly a late colonizer during biofilm formation and adheres to biofilms previously formed by primary colonizers such as Streptococcus Gordonii35. In our animal models, we transplanted P. gingivalis only, without primary colonizers, and did not determine whether an ionic silver coating would inhibit biofilm formation by P. gingivalis. Further studies are needed to investigate additional effects of ionic silver coating on the complex process of biofilm formation. More complex imaging and biofilm studies are a future direction of the effects of ionic silver coating on the inhibition of biofilm formation implants.
Others have reported that exposing cells to a metal material coated with silver ions using a combination of HAp and IP6 is not toxic to cells14. Indeed, we found that P. gingivalis-dependent osteonecrosis was significantly decreased in the presence of silver ion-coated rods made of titanium, the material most frequently used in bone implants. Some report that a high temperature is required to silver-coat implants36,37. Here, we show that titanium rods can be coated with ionic silver using HAp and IP6 without high temperature, and that those rods exhibit anti-P. gingivalis activity. This suggests that comparable methods could be applied to coat non-metallic implant material, such as plastic or polyethylene, with silver ions without using high temperatures. Thus, overall our study suggests that antimicrobial implants against a wide range of bacteria could be made from a variety of materials.
Materials and methods
Antibacterial effect of Ag+ ions and ionic-silver coating
Porphyromonas gingivalis (P. gingivalis) W83 was grown anaerobically (5% CO2, 10% H2, balanced N2) in BHIHM medium, which consisted of BactoTM Brain Heart Infusion (BHI; Becton Dickinson, Franklin Lakes, NJ, USA), 7.7 μM hemin, and 2.9 μM menadione. An aliquot (50 μl) of a late-log PG culture (~ 0.3 optical density 650 nm (OD650)) was streaked uniformly across a BHIHM agar plate using a disposable inoculation loop. BHIHM agar consisted of 1.5% (w/v) BactoTM Agar (Becton Dickinson) in BHIHM medium. Then, unmodified (control) Ti, HAp-Ti, HAp-IP6-Ti, or HAp-IP6-Ag + (5)–Ti pins were separately placed on the agar and incubated 5 days anaerobically at 37 °C. The inhibition zone was calculated using equation, where D1 and D2 are the area of the respective inhibition zone and the testing pin: Inhibition zone = D1–D2 (Fig. 2). We also spotted twofold serial dilutions of AgNO3 (2 μl each) on the agar and incubated plates 48 h anaerobically at 37 °C. P. gingivalis growth was determined by measuring the OD650 with a SpectraMax Plus 384 (Molecular Devices, Sunnyvale, CA, USA).
Mouse infectious osteomyelitis model
C57BL/6 background wild-type mice were purchased from Sankyo Labo Service (Tokyo, Japan). Mice were maintained under specific pathogen-free (SPF) conditions in animal facilities certified by the Keio University Institutional Animal Care and Use Committee, and animal protocols were approved by that committee. Mice were housed up to 5 per cage and kept on a 12 h light/dark cycle. Sterile distilled water and a standard diet (CLEA Rodent Diet CE-2, Japan) were available ad libitum. All mouse studies were performed in accordance with Institutional Guidelines on Animal Experimentation at Keio University of The Keio University Institutional Animal Care and Use Committee. For surgery, all mice received a mixture of ketamine (100 mg/ kg) and xylazine (10 mg/kg) by intraperitoneal injection as anesthesia, and the skin of the left knee was sterilized with povidone iodine, as previously described38,39. A skin incision was made over that knee, and the distal femur was exposed. A drill and 23G needle were used to make a hole at the distal end of the femur, and a 0.5 × 8-mm titanium alloy bar was inserted into the mouse femur along with an inoculation of P. gingivalis 4.37 × 108 CFU/ml) (for the HAp-IP6-Ag+ coating implant group, N = 6). The same technique was used for the control Ti-HAp-IP6 implant group (N = 6). Mice were monitored for a week. This study is reported in accordance with ARRIVE guidelines.
Detection of Porphyromonas gingivalis by a fluorescence probe in vivo
To visualize an infectious region by P. gingivalis osteomyelitis, we used the IVISense Bacterial 750 Fluorescent Probe (Chemiluminescent reagent: Summit Pharmaceuticals International Co.). This system detects and monitors the extent of bacterial growth in animals based on fluorescent intensity. Specifically, we simultaneously inoculated the femur of test mice with P. gingivalis and intraperitoneally administered 100 μl of the NIR-fluorescent bacterial detection probe. Mice were anesthetized and monitored at days 1, 3 or 7 after surgery by inhalation of aerosolized 1.5% isoflurane mixed with oxygen. The NIR probe was injected on each imaging day (PODs 1, 3, and 7), and the bacterial probe fluorescence was captured using the trans-illumination feature of the IVIS® Lumina optical-imaging system.
Histological and fluorescent immunohistochemical analyses
We collected femur specimens on day 14 after surgery for histological analysis. To do so, animals were euthanized, femurs removed and separated from soft tissues, and samples were then fixed in 4% PFA in 0.1 M PBS, demineralized with 10% ethylenediaminetetraacetic acid, embedded in paraffin, cut into 5-μm-thick sections, and Hematoxylin and Eosin-stained (HE). Empty lacunae were detected in femur sections following HE staining, and the percentage of empty lacunae was calculated relative to total (empty + undamaged) lacunae.
For immunohistochemistry, sections were subjected to microwave treatment for 10 min in 10 mM citrate buffer solution (pH 6.0) for antigen retrieval, as described40. After blocking 1 h with 3% BSA in PBS, sections were stained using mouse anti-P. gingivalis mAb (D376-3 1:100 Medical & Biological Laboratories Co.,LTD, Tokyo, Japan), followed by Alexa546-conjugated goat anti-Mouse IgG (#A-11030 1:200; Invitrogen, Carlsbad, CA, USA). Nuclei were visualized by DAPI (#D1306 1:750; Wako Pure Chemicals Industries, Osaka, Japan).
Cell cytotoxicity assay.
Cell culture
Murine osteoblastic cells (MC3T3-E1) were cultured in α-MEM (Sigma-Aldrich, St. Louis, MO) containing 10% heat-inactivated fetal bovine serum (FBS) (SAFC Biosciences) and GlutaMax (Invitrogen, Carlsbad, CA) at 37 °C under 5% CO2 air. Medium was changed every 48 h, and cells were passaged using TrypLE™ Express Enzyme (1X) with no phenol red (Thermo Fisher Scientific K.K, Massachusetts, USA) once a week when they reached 90% confluence. Proliferation of MC3T3-E1 cells cocultured with HAp-IP6-Ag + -coated or uncoated Ti-HAp-IP6 implants was examined using 12-well Multiwell TC Plates (Corning, NY). First, MC3T3-E1 cells were seeded onto plates at a density of 6 × 104 cells per well in 2 ml medium and incubated 24 h. Then, an HAp-IP6-Ag + -coated or uncoated Ti-HAp-IP6 implant was placed in each well. Cells cultured for 3 days and observed under a phase-contrast microscope. Finally, cells were harvested and counted.
Enzyme-linked immunosorbent assay (ELISA)
Serum CRP and IL-6 ELISA assays were undertaken following the manufacturer's instructions (R&D Systems, Minneapolis, MN, USA) using a multiple plate analyzer (Cytation 5, BioTek Instruments, Inc., Winooski, VT, USA).
Statistical analysis
Quantified data are shown as means ± SD. Statistical significance of differences between or among groups was evaluated using Student’s t test, the Mann–Whitney U test or a one-way analysis of variance (ANOVA), respectively, using statistical software (version 25; SPSS Inc., Chicago, IL, USA) (*P < 0.05; **P < 0.01; ***P < 0.001; NS, not significant, throughout the paper) as previously described40.
Data availability
The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.
References
Bartlet, K., Movafaghi, S., Dasi, L. P., Kota, A. K. & Popat, K. C. Antibacterial activity on superhydrophobic titania nanotube arrays. Colloids Surf. B Biointerfaces 166, 179–186. https://doi.org/10.1016/j.colsurfb.2018.03.019 (2018).
Mishra, B. & Wang, G. Titanium surfaces immobilized with the major antimicrobial fragment FK-16 of human cathelicidin LL-37 are potent against multiple antibiotic-resistant bacteria. Biofouling 33, 544–555. https://doi.org/10.1080/08927014.2017.1332186 (2017).
Depypere, M. et al. Pathogenesis and management of fracture-related infection. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 26, 572–578. https://doi.org/10.1016/j.cmi.2019.08.006 (2020).
López-Cerero, L. Dental implant-related infections. Enferm. Infecc. Microbiol. Clin. 26, 589–592. https://doi.org/10.1157/13128277 (2008).
Oikonomidis, S. et al. Implant-associated infection of long-segment spinal instrumentation: A retrospective analysis of 46 consecutive patients. Asian Spine J. 15, 234–243. https://doi.org/10.31616/asj.2019.0391 (2021).
Stokman, M. A., van Winkelhoff, A. J., Vissink, A., Spijkervet, F. K. & Raghoebar, G. M. Bacterial colonization of the peri-implant sulcus in dentate patients: A prospective observational study. Clin. Oral Invest. 21, 717–724. https://doi.org/10.1007/s00784-016-1941-x (2017).
Sgolastra, F., Petrucci, A., Severino, M., Gatto, R. & Monaco, A. Periodontitis, implant loss and peri-implantitis. A meta-analysis. Clin. Oral Implants Res. 26, e8–e16. https://doi.org/10.1111/clr.12319 (2015).
Stachler, E., Kull, A. & Julian, T. R. Bacteriophage treatment before chemical disinfection can enhance removal of plastic-surface-associated Pseudomonas aeruginosa. Appl. Environ. Microbiol. 87, e0098021. https://doi.org/10.1128/aem.00980-21 (2021).
Köder, K. et al. Outcome of spinal implant-associated infections treated with or without biofilm-active antibiotics: results from a 10-year cohort study. Infection 48, 559–568. https://doi.org/10.1007/s15010-020-01435-2 (2020).
Zimmerli, W. & Sendi, P. Orthopaedic biofilm infections. APMIS Acta Pathol. Microbiol. Immunol. Scand. 125, 353–364. https://doi.org/10.1111/apm.12687 (2017).
Donlan, R. M. & Costerton, J. W. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167–193. https://doi.org/10.1128/cmr.15.2.167-193.2002 (2002).
Veerachamy, S., Yarlagadda, T., Manivasagam, G. & Yarlagadda, P. K. Bacterial adherence and biofilm formation on medical implants: A review. Proc. Inst. Mech. Eng. Part H J. Eng. Med. 228, 1083–1099. https://doi.org/10.1177/0954411914556137 (2014).
Honda, M. et al. In vitro and in vivo antimicrobial properties of silver-containing hydroxyapatite prepared via ultrasonic spray pyrolysis route. Mater. Sci. Eng. C Mater. Biol. Appl. 33, 5008–5018. https://doi.org/10.1016/j.msec.2013.08.026 (2013).
Funao, H. et al. A novel hydroxyapatite film coated with ionic silver via inositol hexaphosphate chelation prevents implant-associated infection. Sci. Rep. 6, 23238. https://doi.org/10.1038/srep23238 (2016).
Ishihama, H. et al. An antibacterial coated polymer prevents biofilm formation and implant-associated infection. Sci. Rep. 11, 3602. https://doi.org/10.1038/s41598-021-82992-w (2021).
Long, Y. M. et al. Surface ligand controls silver ion release of nanosilver and its antibacterial activity against Escherichia coli. Int. J. Nanomed. 12, 3193–3206. https://doi.org/10.2147/ijn.S132327 (2017).
Wang, X. et al. The synergistic antibacterial activity and mechanism of multicomponent metal ions-containing aqueous solutions against Staphylococcus aureus. J. Inorg. Biochem. 163, 214–220. https://doi.org/10.1016/j.jinorgbio.2016.07.019 (2016).
Irshad, M. et al. Influence of titanium on in vitro fibroblast-Porphyromonas gingivalis interaction in peri-implantitis. J. Clin. Periodontol. 40, 841–849. https://doi.org/10.1111/jcpe.12136 (2013).
Lafaurie, G. I. et al. Microbiome and microbial biofilm profiles of peri-implantitis: A systematic review. J. Periodontol. 88, 1066–1089. https://doi.org/10.1902/jop.2017.170123 (2017).
Tzach-Nahman, R., Mizraji, G., Shapira, L., Nussbaum, G. & Wilensky, A. Oral infection with Porphyromonas gingivalis induces peri-implantitis in a murine model: Evaluation of bone loss and the local inflammatory response. J. Clin. Periodontol. 44, 739–748. https://doi.org/10.1111/jcpe.12735 (2017).
Le Guéhennec, L., Soueidan, A., Layrolle, P. & Amouriq, Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent. Mater. Off. Publ. Acad. Dent. Mater. 23, 844–854. https://doi.org/10.1016/j.dental.2006.06.025 (2007).
Antoszewska, J., Raftowicz-Wójcik, K., Kawala, B. & Matthews-Brzozowska, T. Biological factors involved in implant-anchored orthodontics and in prosthetic-implant therapy: A literature review. Arch. Immunol. Ther. Exp. 58, 379–383. https://doi.org/10.1007/s00005-010-0088-8 (2010).
Jing, Z. et al. Functionalization of 3D-printed titanium alloy orthopedic implants: A literature review. Biomed. Mater. (Bristol, England) 15, 052003. https://doi.org/10.1088/1748-605X/ab9078 (2020).
Feihl, S., Renz, N., Schütz, M. & Müller, M. Antibiotic strategies in trauma surgery: Treatment of implant-associated infections. Unfallchirurg 120, 486–493. https://doi.org/10.1007/s00113-017-0359-5 (2017).
Dharan, S. & Pittet, D. Environmental controls in operating theatres. J. Hosp. Infect. 51, 79–84. https://doi.org/10.1053/jhin.2002.1217 (2002).
Davat, M. et al. Should antibiotic prophylaxis before orthopedic implant surgery depend on the duration of pre-surgical hospital stay?. Antimicrob. Resist. Infect. Control 7, 131. https://doi.org/10.1186/s13756-018-0421-2 (2018).
Tucci, G. et al. Prevention of surgical site infections in orthopaedic surgery: A synthesis of current recommendations. Eur. Rev. Med. Pharmacol. Sci. 23, 224–239. https://doi.org/10.26355/eurrev_201904_17497 (2019).
Tsuchiya, H. et al. Innovative antimicrobial coating of titanium implants with iodine. J. Orthop. Sci. Off. J. Jpn. Orthop. Assoc. 17, 595–604. https://doi.org/10.1007/s00776-012-0247-3 (2012).
Chouirfa, H., Bouloussa, H., Migonney, V. & Falentin-Daudré, C. Review of titanium surface modification techniques and coatings for antibacterial applications. Acta Biomater. 83, 37–54. https://doi.org/10.1016/j.actbio.2018.10.036 (2019).
Qiao, S. et al. Ag-plasma modification enhances bone apposition around titanium dental implants: An animal study in Labrador dogs. Int. J. Nanomed. 10, 653–664. https://doi.org/10.2147/ijn.S73467 (2015).
van Hengel, I. A. J., Tierolf, M., Fratila-Apachitei, L. E., Apachitei, I. & Zadpoor, A. A. Antibacterial titanium implants biofunctionalized by plasma electrolytic oxidation with silver, zinc, and copper: A systematic review. Int. J. Mol. Sci. https://doi.org/10.3390/ijms22073800 (2021).
Jung, W. K. et al. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl. Environ. Microbiol. 74, 2171–2178. https://doi.org/10.1128/aem.02001-07 (2008).
Li, Y. Y. et al. Effects of D-arginine on Porphyromonas gingivalis biofilm. J. Oral Sci. 62, 57–61. https://doi.org/10.2334/josnusd.19-0075 (2020).
Montazeri, A., Salehzadeh, A. & Zamani, H. Effect of silver nanoparticles conjugated to thiosemicarbazide on biofilm formation and expression of intercellular adhesion molecule genes, icaAD, in Staphylococcus aureus. Folia Microbial. 65, 153–160. https://doi.org/10.1007/s12223-019-00715-1 (2020).
Sweidan, A. et al. Antibacterial activities of natural lichen compounds against Streptococcus gordonii and Porphyromonas gingivalis. Fitoterapia 121, 164–169. https://doi.org/10.1016/j.fitote.2017.07.011 (2017).
Noda, I. et al. Development of novel thermal sprayed antibacterial coating and evaluation of release properties of silver ions. J. Biomed. Mater. Res. Part B Appl. Biomater. 89, 456–465. https://doi.org/10.1002/jbm.b.31235 (2009).
Wang, J.-X., Wen, L.-X., Wang, Z.-H. & Chen, J.-F. Immobilization of silver on hollow silica nanospheres and nanotubes and their antibacterial effects. Mater. Chem. Phys. 96, 90–97. https://doi.org/10.1016/j.matchemphys.2005.06.045 (2006).
Morita, M. et al. Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis. Sci. Rep. 7, 46322. https://doi.org/10.1038/srep46322 (2017).
Shiono, Y. et al. Delayed Propionibacterium acnes surgical site infections occur only in the presence of an implant. Sci. Rep. 6, 32758. https://doi.org/10.1038/srep32758 (2016).
Soma, T. et al. Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw. J. Bone Miner. Metab. 39, 372–384. https://doi.org/10.1007/s00774-020-01174-2 (2021).
Acknowledgements
T. Miyamoto was supported by a grant-in-aid for Scientific Research in Japan and a grant from the Japan Agency for Medical Research and Development. Y. Sato and K. Miyamoto were supported by a grant-in-aid for Scientific Research in Japan. This study was supported in part by Shionogi & Co., Ltd. The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.
Author information
Authors and Affiliations
Contributions
Investigation: T.S., Y.S., T.K., K.S., Z.X.; conceptualization: T.M. (Miyamoto); data curation: R.I., E.I., T.M. (Matsumoto), A.K., F.H., K.M. and M.M. (Morita); funding acquisition: R.I., Y.S., K.M. and T.M. (Miyamoto); supervision: R.I., Y.T., M.M. (Matsumoto), M.N., K.I., S.A., H.K., M.A., T.N. and T.M. (Miyamoto); writing: T.M. (Miyamoto).
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Soma, T., Iwasaki, R., Sato, Y. et al. An ionic silver coating prevents implant-associated infection by anaerobic bacteria in vitro and in vivo in mice. Sci Rep 12, 18387 (2022). https://doi.org/10.1038/s41598-022-23322-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-23322-6
- Springer Nature Limited